Capstone Investment Advisors, LLC Provention Bio, Inc. Transaction History
Capstone Investment Advisors, LLC
- $29.5 Billion
- Q2 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Provention Bio, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 100,000 shares of PRVB stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$0% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PRVB
# of Institutions
1Shares Held
170KCall Options Held
0Put Options Held
0About Provention Bio, Inc.
- Ticker PRVB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 81,549,904
- Description
- Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...